West Pharmaceutical Services, Inc. (WST) Financials

WST Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 4.1 billion 1.1 billion
March 31, 2026 4.1 billion 1.1 billion
Dec. 31, 2025 4.3 billion 1.1 billion
Sept. 30, 2025 4.1 billion 1.1 billion

WST Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 80.8 million 10.9 million
March 31, 2026 47.2 million 6.6 million
Dec. 31, 2025 175.0 million 6.7 million
Sept. 30, 2025 133.9 million 8.4 million

WST Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 154.0 million
March 31, 2026 138.8 million
Dec. 31, 2025 132.1 million
Sept. 30, 2025 140.0 million

WST Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 435.8 million 291.2 million 109.2 million
March 31, 2026 521.4 million 202.8 million 113.4 million
Dec. 31, 2025 791.3 million 202.8 million 118.3 million
Sept. 30, 2025 628.5 million 202.7 million 94.9 million

WST Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 71.3 million
March 31, 2026 72.4 million
Dec. 31, 2025 72.7 million
Sept. 30, 2025 72.7 million

WST Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 43.2 million 19.7 million 117.6 million -
March 31, 2026 42.7 million 15.8 million 99.5 million -
Dec. 31, 2025 76.1 million 21.8 million 106.5 million -
Sept. 30, 2025 63.3 million 17.1 million 102.7 million -

WST Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 872.3 million 543.1 million
March 31, 2026 844.9 million 548.5 million
Dec. 31, 2025 805.0 million 501.1 million
Sept. 30, 2025 804.3 million 510.8 million

WST Revenue by Segment
Graph available only for paid members. Upgrade to see it.

WST

List: Champions

Price: $366

52 week price:
223.83
386.00

Dividend Yield: 0.23%

5-year range yield:
0.17%
0.38%

Forward Dividend Yield: 0.24%

Payout Ratio: 11.36%

Payout Ratio Range:
-416.00%
850.00%

Dividend Per Share: 0.88 USD

Earnings Per Share: 7.95 USD

P/E Ratio: 42.39

Exchange: NYQ

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

Volume: 800100

Ebitda: 85.9 million

Market Capitalization: 26.4 billion

Average Dividend Frequency: 4

Years Paying Dividends: 42

DGR3: 5.27%

DGR5: 5.59%

DGR10: 6.69%

DGR20: 6.94%

Links: